Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Non-Current Assets: 2011-2024

Historic Other Non-Current Assets for Gyre Therapeutics (GYRE) over the last 13 years, with Dec 2024 value amounting to $6.3 million.

  • Gyre Therapeutics' Other Non-Current Assets rose 92.41% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 92.41%. This contributed to the annual value of $6.3 million for FY2024, which is 531.16% up from last year.
  • According to the latest figures from FY2024, Gyre Therapeutics' Other Non-Current Assets is $6.3 million, which was up 531.16% from $995,000 recorded in FY2023.
  • Gyre Therapeutics' 5-year Other Non-Current Assets high stood at $6.3 million for FY2024, and its period low was $472,000 during FY2021.
  • In the last 3 years, Gyre Therapeutics' Other Non-Current Assets had a median value of $3.4 million in 2022 and averaged $3.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 619.07% in 2022, then plummeted by 70.68% in 2023.
  • Gyre Therapeutics' Other Non-Current Assets (Yearly) stood at $528,000 in 2020, then fell by 10.61% to $472,000 in 2021, then soared by 619.07% to $3.4 million in 2022, then plummeted by 70.68% to $995,000 in 2023, then skyrocketed by 531.16% to $6.3 million in 2024.